Skip to main content

Table 2 Multivariable analysis

From: Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

Variable

PFS as the dependent variable

OS as the dependent variable

Univariate

Multivariable

Univariate

Multivariable

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-value

Baseline LDH

2.79 (1.55–5.03)

< 0.001

  

3.37 (1.65–6.89)

< 0.001

  

Baseline CRP

2.38 (1.28–4.42)

0.006

2.16 (1.15–4.07)

0.017

2.43 (1.17–5.06)

0.017

  

ECOG

2.87 (1.20–6.90)

0.018

2.67 (1.04–6.84)

0.04

4.02 (1.65–9.79)

0.002

  

Number of metastatic sites

2.33 (1.28–4.26)

0.006

  

3.06 (1.44–6.52)

0.004

2.38 (1.10–5.14)

0.027

Undetectable ctDNA

0.18 (0.09–0.35)

< 0.001

0.20 (0.10–0.40)

< 0.001

0.13 (0.06–0.29)

< 0.001

0.16 (0.07–0.36)

< 0.001

  1. Univariate and multivariable regression analyses were performed using cox regression model. Factors associated with the occurrence of OS and PFS (ctDNA, LDH, CRP, number of tumor sites and ECOG variables) were considered in the analyses. The results are presented as hazard ratios with 95% confidence intervals and p values